Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s): ACHFF

Technology Scientific & Technical Instruments

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

Add To Watchlist

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > 7 Months …..

View:

Post by Viking2233 on Oct 06, 2024 5:21pm

7 Months …..

How long does it take in Canada to get ethics approval and provincial approval for drug trial????? We have FDA and Health Canada approval plus we have been dosing in Turkey at 5 sites with no adverse reactions.

This is out of Arch managements' control and no reflection on them. There is something obviously wrong with the Candian approval process!!

We are all excited about the Pontiac Trial but they also need to obtain these approvals before dosing starts. I can only imagine how long it will take for dosing to commence in Pontiac trial considering the Metablok trial was announced many months prior to Pontiac trial.

263